aspirin

Generic: aspirin

Labeler: topco associates, llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler topco associates, llc
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
Topco Associates, LLC

Identifiers & Regulatory

Product NDC 36800-545
Product ID 36800-545_b0614294-64cf-4cf1-9f89-19cb5fa3801f
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2021-03-19

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 36800545
Hyphenated Format 36800-545

Supplemental Identifiers

RxCUI
308416
UPC
0036800109537
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (36800-545-60) / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

36800-545-60 1 BOTTLE, PLASTIC in 1 CARTON (36800-545-60) / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b0614294-64cf-4cf1-9f89-19cb5fa3801f", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0036800109537"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["56c125de-fabf-41fa-88a4-760d2793f202"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Topco Associates, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (36800-545-60)  / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC", "package_ndc": "36800-545-60", "marketing_start_date": "20210319"}], "brand_name": "Aspirin", "product_id": "36800-545_b0614294-64cf-4cf1-9f89-19cb5fa3801f", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "36800-545", "generic_name": "Aspirin", "labeler_name": "Topco Associates, LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210319", "listing_expiration_date": "20261231"}